Escolar Documentos
Profissional Documentos
Cultura Documentos
SlideMelasma DraAnaPaulaPujolMBNE
SlideMelasma DraAnaPaulaPujolMBNE
471-72
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
MELANOSSOMAS E MELANINA
SHETH, Vaneeta M.; PANDYA, Amit G. Melasma: a comprehensive update: part II. Journal of the American Academy of Dermatology, v. 65, n. 4, p. 699-714, 2011.
ESPÓSITO, Ana Cláudia C. et al. Update on Melasma—Part I: Pathogenesis. Dermatology and Therapy, v. 12, n. 9, p. 1967-1988, 2022.
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
TRATAMENTO
MITF
CASSIANO, Daniel P. et al. Update on Melasma—Part II: Treatment. Dermatology and Therapy, v. 12, n. 9, p. 1989-2012, 2022.
ESPÓSITO, Ana Cláudia C. et al. Update on Melasma—Part I: Pathogenesis. Dermatology and Therapy, v. 12, n. 9, p. 1967-1988, 2022.
SEÇKIN, Havva Yıldız et al. Oxidative stress status in patients with melasma. Cutaneous and Ocular Toxicology, v. 33, n. 3, p. 212-217, 2014.
ESPÓSITO, Ana Cláudia C. et al. Update on Melasma—Part I: Pathogenesis. Dermatology and Therapy, v. 12, n. 9, p. 1967-1988, 2022.
SEÇKIN, Havva Yıldız et al. Oxidative stress status in patients with melasma. Cutaneous and Ocular Toxicology, v. 33, n. 3, p. 212-217, 2014.
1. Agentes de fotoproteção
3. Procedimentos de recapeamento.
CASSIANO, Daniel P. et al. Update on Melasma—Part II: Treatment. Dermatology and Therapy, v. 12, n. 9, p. 1989-2012, 2022.
CASSIANO, Daniel P. et al. Update on Melasma—Part II: Treatment. Dermatology and Therapy, v. 12, n. 9, p. 1989-2012, 2022.
Antioxidante, anti-inflamatório
I C Aa nutrição
PYCNOGENOL Inibidor da tirosinase e anti iNOS
PINUS PINASTER
ST
G I A P L ÁO que
Fotoproteção - eritema
C I R U RMelasma:
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
Redução 58% do MASI em 31
mulheres brasileiras
PINTO, Camila Araujo Scharf et al. Uso do pycnogenol no tratamento do melasma. Surgical & Cosmetic Dermatology, v. 7, n. 3, p. 218-222, 2015.
NI, Z.; MU, Y.; GULATI, O. Treatment of melasma with Pycnogenol®. Phytotherapy Research: An International Journal Devoted to Pharmacological
and Toxicological Evaluation of Natural Product Derivatives, v. 16, n. 6, p. 567-571, 2002.
75 mg de picnogenol (PYC) por via oral ou um placebo (PLAC) 2x por dia durante 60 dias.
(Ambos os grupos também receberam filtro solar com (SPF) 50; para uso diurno e uma combinação tópica tripla ao deitar
LIMA, P. B. et al. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a
double‐blind, randomized, placebo‐controlled trial. Journal of the European Academy of Dermatology and Venereology, v. 35, n. 2, p. 502-508, 2021.
LIMA, P. B. et al. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a
double‐blind, randomized, placebo‐controlled trial. Journal of the European Academy of Dermatology and Venereology, v. 35, n. 2, p. 502-508, 2021.
LIMA, P. B. et al. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
double‐blind, randomized, placebo‐controlled trial. Journal of the European Academy of Dermatology and Venereology, v. 35, n. 2, p. 502-508, 2021.
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
POLYPODIUM LOUCOTOMOS
GRIMES, P. E. et al. New oral and topical approaches for the treatment of melasma. International Journal of Women's Dermatology, v. 5, n. 1, p. 30-36, 2019.
I C Aa nutrição
POLYPODIUM LOUCOTOMOS endógenos
MECANISMO
que
Bloqueio da expressão da ciclooxigenase-2
ST
G I A P L ÁO
C I R U RMelasma:
induzida por radiação UV
GRIMES, P. E. et al. New oral and topical approaches for the treatment of melasma. International Journal of Women's Dermatology, v. 5, n. 1, p. 30-36, 2019.
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72
Em um estudo randomizado, controlado por placebo com 40
pacientes, 240 mg duas vezes ao dia versus placebo por 12 semanas
➢ Inibição da tirosinase
CASSIANO, Daniel P. et al. Update on Melasma—Part II: Treatment. Dermatology and Therapy, v. 12, n. 9, p. 1989-2012, 2022.
ARJINPATHANA, Nutthavuth; ASAWANONDA, Pravit. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. Journal of
dermatological treatment, v. 23, n. 2, p. 97-102, 2012.
ARJINPATHANA, Nutthavuth; ASAWANONDA, Pravit. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. Journal of
Conteúdo licenciado para Izabel Cristina Almeida Lopes - 950.135.471-72 dermatological treatment, v. 23, n. 2, p. 97-102, 2012.
30 MULHERES COM TIPOS
DE PELE FITZPATRICK IV OU V
HANDOG, Evangeline B.; DATUIN, Maria Suzanne L.; SINGZON, Ivan A. An open‐label, single‐arm trial of the safety and efficacy of a novel preparation of
glutathione as a skin‐lightening agent in F ilipino women. International journal of dermatology, v. 55, n. 2, p. 153-157, 2016.
HANDOG, Evangeline B.; DATUIN, Maria Suzanne L.; SINGZON, Ivan A. An open‐label, single‐arm trial of the safety and efficacy of a novel preparation of
glutathione as a skin‐lightening agent in F ilipino women. International journal of dermatology, v. 55, n. 2, p. 153-157, 2016.
Frutooligossacarídeo e inulina
Durante 12 semanas
PIYAVATIN, Piyanat et al. Synbiotics supplement is effective for Melasma improvement. Journal of Cosmetic Dermatology, v. 20, n. 9, p. 2841-2850, 2021.
PIYAVATIN, Piyanat et al. Synbiotics supplement is effective for Melasma improvement. Journal of Cosmetic Dermatology, v. 20, n. 9, p. 2841-2850, 2021.
GLUTATIONA!
N baixo